Navigation Links
terna Zentaris Discloses First In Vitro Data for its PI3K,,,Inhibitors at the AACR Annual Meeting in Los Angeles

collected. Several derivatives are currently undergoing first pharmacokinetic in vivo studies.

About terna Zentaris Inc.

terna Zentaris Inc. is a global, pure play biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aeternazentaris.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes", "anticipates", "intends", "plans", "expects", "estimates", "will," "may", "should", "approximately", and the negative or other variations of those terms or comparable terminology, are forward-looking statements. Such statements reflect management's current views, intentions, strategies and plans and are based on certain assumptions.

Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford

Post Your Comments:
(Date:11/6/2009)...6 Chimerix, Inc., a biopharmaceuti...herapeutics to address life-threatening diseases, ...y,s lead antiviral compound, CMX001, to the World ...curity Initiative (GHSI). CMX001 is a broad-spect...ent of smallpox, as well as other serious viral in...
(Date:11/6/2009)...alifornia American Water has designated the week o...ek for its San Diego County service area as part o...ate agencies alike toward the common mission of re...r supplies. ,, California American Water,s San ...expired or unwanted pharmaceuticals free of charge...
(Date:11/5/2009)...-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "H... II trial of Topical Interferon Alpha-2b for the t...patient enrollment, with the required 120th patien...blind and placebo-controlled Phase II trial is und...Patients participating in the trial self-administe...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6DIA Workshop Features Industry and FDA for Discussion of Best Practices for Electronic Establishment Registration and Product Listing 51231 1DIA Workshop Features Industry and FDA for Discussion of Best Practices for Electronic Establishment Registration and Product Listing 51231 2Netsmart Technologies Ranked in Healthcare Informatics Top 100 51228 1Netsmart Technologies Ranked in Healthcare Informatics Top 100 51228 2Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes 51225 1Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes 51225 2Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes 51225 3
...WIRE)--Jun 29, 2007 - Reata,Pharmaceuticals, Inc. ...l data showing their lead anti-cancer agent, the,S...tecting against,common toxicities caused by tradit...t the annual meeting of the Multinational,Associat...len,Switzerland., Reata scientists and collaborat...
...cervical cancer vaccine has shown 90%,efficacy for...sions,associated with the human papillomavirus (HP... of an Article published early Online,and in the u...account for 70% or more,cases of cervical cancer w...es which can contribute to cervical cancer. , Prof...
Other Medicine Technology:RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
(Date:11/8/2009)...PRNewswire-USNewswire/ -- The American Public Heal...wellness provisions in the health reform bill pass... this bill, the House takes important steps toward...e reforms and moving our health system from one th...s on keeping people healthy," said Georges C. Benj...
(Date:11/8/2009)...W Academy of Health holds open house at Victoria c...us) November 8, 2009 -- UCW Academy of Health invi...lumbia’s health care industry to attend thei..., 2009. , ,UCW Academy of Health, which offers di...d social services, designs its programs to meet th...
(Date:11/8/2009)...Newswire-USNewswire/ -- Speaker Nancy Pelosi and D...g the House passage of H.R. 3962, the Affordable H...vote of 220 to 215. Below are the Speaker,s openi...st received a call from the President of the Unite...at victory for the American people. I thank the Pr...
(Date:11/8/2009)... Global Solutions is pleased to announce that it h...l effort for ReSound who recently received an awar...act. The award includes not only the Veterans Admi... other federal agencies. , ...al Solutions is pleased to announce that it has be...
(Date:11/8/2009)...jury of 8 people in the Western District of Pennsy...pain and suffering for a medical malpractice case....ia Nocera of Thomas E. Crenney and Associates, LLC... Monestersky and against the Uniontown Hospital. ... hysterectomy at age 18. , ...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2
...ternational team of researchers were studying Bard... lacks proper functional cilia gets lodged in the...s which are in the brain which control appetite ar...kidney failure. Eight faulty genes are thought...
...vate hospital group in South Africa will be recrui...ff the country faces. // Estelle Jordaan, Directo...ily Beeld here that a team from the private hospit...stern Cape Province, where the shortage of staff i...
...tists have warned that the improper usage of MP3 a... can contribute towards affecting the hearing capa...n’s Director of Audiology Paul R. Kileny revealed ...use them for hours together, which will definitely...
...ren who suffer from limb disabilities are being pr... by India’s Paraplegia Hospital in the City of Ahe...nd it is providing the services without any public...the benefits of this program. The hospital'...
...ayne Katon, a professor of psychiatry at the Unive...patients who are treated for depression don’t show...ation in their habits. // But along with th...blished in the journal Annals of Family Medicine. ...
...tists belonging to the Brown University have revea...ted to the aging of the cells. // This conclusion ...tween 5 and 30 years, wherein it was found that as...f the body are linked may seem obvious, but the la...
Other Medicine News:Health News:Depression plays a vital role in Diabetes 2
Creatine Kinase Kinetic Reagent
Creatine Kinase-MB (CK-MB)
Magnesium
Glucose UV Liquidplus
Medicine Products: